Matthew L. Posard - 02 Dec 2022 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
Director
Signature
/s/ James Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
02 Dec 2022
Transactions value $
-$1,706,550
Form type
4
Filing time
06 Dec 2022, 18:07:45 UTC
Previous filing
16 Jun 2022
Next filing
09 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Sale -$588K -10K -7.4% $58.80 125K 02 Dec 2022 Direct F1
transaction HALO Common Stock Sale -$557K -10K -7.99% $55.74 115K 05 Dec 2022 Direct F2
transaction HALO Common Stock Sale -$561K -10K -8.68% $56.12 105K 06 Dec 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average sales price per share. The shares were sold at prices ranging from $58.80 to $58.83. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2 Represents a weighted average sales price per share. The shares were sold at prices ranging from $55.70 to $55.83. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 Represents a weighted average sales price per share. The shares were sold at prices ranging from $56.10 to $56.19. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.